Your browser doesn't support javascript.
loading
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
Bourhis, Jean-Henri; Bouko, Yasmina; Koscielny, Serge; Bakkus, Marleen; Greinix, Hildegard; Derigs, Gunter; Salles, Gilles; Feremans, Walter; Apperley, Jane; Samson, Diana; Björkstrand, Bo; Niederwieser, Dietger; Gahrton, Gösta; Pico, José-Luis; Goldschmidt, Hartmut.
Afiliação
  • Bourhis JH; Division of Hematology, Department of Medicine, Institut Gustave Roussy, 94800 Villejuif, France. jhb@igr.fr
Haematologica ; 92(8): 1083-90, 2007 Aug.
Article em En | MEDLINE | ID: mdl-17640853
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purging da Medula Óssea / Transplante de Células-Tronco de Sangue Periférico / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purging da Medula Óssea / Transplante de Células-Tronco de Sangue Periférico / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2007 Tipo de documento: Article